Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Hyphens-Wynzora

More Like This

PR Newswire associated0

Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China

Incyte Announces Results of Phase 3 Clinical Trials Evaluating Ruxolitinib Cream 1.5% (Opzelura®) in Patients with Prurigo Nodularis (PN) at 2025 American Academy of Dermatology Annual Meeting

APOTEX LICENSES EXCLUSIVE CANADIAN RIGHTS TO QUTENZA® FROM GRÜNENTHAL

Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe

PR Newswire associated0

Wingderm® "Dual Innovation, Infinite Possibilities" Global Distributor conference was successfully held at IMCAS

PR Newswire associated0

Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa

ACCESSWIRE associated0

GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis